nodes	percent_of_prediction	percent_of_DWPC	metapath
Disopyramide—ORM1—Erlotinib—kidney cancer	0.154	0.29	CbGbCtD
Disopyramide—SLC22A2—Vinblastine—kidney cancer	0.102	0.193	CbGbCtD
Disopyramide—CYP3A4—Everolimus—kidney cancer	0.0803	0.151	CbGbCtD
Disopyramide—CYP3A4—Temsirolimus—kidney cancer	0.0543	0.102	CbGbCtD
Disopyramide—CYP3A4—Pazopanib—kidney cancer	0.0285	0.0537	CbGbCtD
Disopyramide—CHRM3—ureter—kidney cancer	0.0241	0.303	CbGeAlD
Disopyramide—CYP3A4—Erlotinib—kidney cancer	0.0203	0.0383	CbGbCtD
Disopyramide—CYP3A4—Paclitaxel—kidney cancer	0.0186	0.0351	CbGbCtD
Disopyramide—SLC22A2—nephron—kidney cancer	0.0167	0.21	CbGeAlD
Disopyramide—CYP3A4—Sorafenib—kidney cancer	0.0165	0.0311	CbGbCtD
Disopyramide—CYP3A4—Vinblastine—kidney cancer	0.0163	0.0307	CbGbCtD
Disopyramide—CYP3A4—Vincristine—kidney cancer	0.0161	0.0302	CbGbCtD
Disopyramide—CYP3A4—Sunitinib—kidney cancer	0.0134	0.0252	CbGbCtD
Disopyramide—CYP3A4—Doxorubicin—kidney cancer	0.01	0.0189	CbGbCtD
Disopyramide—KCND3—cortex of kidney—kidney cancer	0.00434	0.0545	CbGeAlD
Disopyramide—CYP3A4—urine—kidney cancer	0.00431	0.0541	CbGeAlD
Disopyramide—KCND3—cardiac atrium—kidney cancer	0.00413	0.0518	CbGeAlD
Disopyramide—SLC22A2—nephron tubule—kidney cancer	0.0036	0.0453	CbGeAlD
Disopyramide—SLC22A2—renal system—kidney cancer	0.00327	0.0411	CbGeAlD
Disopyramide—SLC22A2—kidney—kidney cancer	0.00317	0.0398	CbGeAlD
Disopyramide—SLC22A2—cortex of kidney—kidney cancer	0.00308	0.0387	CbGeAlD
Disopyramide—SCN5A—cardiac atrium—kidney cancer	0.00248	0.0311	CbGeAlD
Disopyramide—SLC22A1—renal system—kidney cancer	0.00231	0.0291	CbGeAlD
Disopyramide—SLC22A1—kidney—kidney cancer	0.00224	0.0281	CbGeAlD
Disopyramide—CHRM3—renal system—kidney cancer	0.00192	0.0241	CbGeAlD
Disopyramide—CHRM3—kidney—kidney cancer	0.00185	0.0233	CbGeAlD
Disopyramide—CYP3A4—renal system—kidney cancer	0.00105	0.0132	CbGeAlD
Disopyramide—CYP3A4—kidney—kidney cancer	0.00102	0.0128	CbGeAlD
Disopyramide—Constipation—Sunitinib—kidney cancer	0.000393	0.00121	CcSEcCtD
Disopyramide—Pruritus—Everolimus—kidney cancer	0.00039	0.0012	CcSEcCtD
Disopyramide—Oedema—Vincristine—kidney cancer	0.000389	0.0012	CcSEcCtD
Disopyramide—Arrhythmia—Paclitaxel—kidney cancer	0.000388	0.00119	CcSEcCtD
Disopyramide—Chest pain—Gemcitabine—kidney cancer	0.000385	0.00118	CcSEcCtD
Disopyramide—Asthenia—Erlotinib—kidney cancer	0.000381	0.00117	CcSEcCtD
Disopyramide—Thrombocytopenia—Vincristine—kidney cancer	0.000381	0.00117	CcSEcCtD
Disopyramide—Discomfort—Gemcitabine—kidney cancer	0.00038	0.00117	CcSEcCtD
Disopyramide—Urticaria—Sorafenib—kidney cancer	0.00038	0.00117	CcSEcCtD
Disopyramide—Decreased appetite—Dactinomycin—kidney cancer	0.000378	0.00116	CcSEcCtD
Disopyramide—Diarrhoea—Vinblastine—kidney cancer	0.000378	0.00116	CcSEcCtD
Disopyramide—Body temperature increased—Sorafenib—kidney cancer	0.000378	0.00116	CcSEcCtD
Disopyramide—Diarrhoea—Everolimus—kidney cancer	0.000377	0.00116	CcSEcCtD
Disopyramide—Hyperhidrosis—Vincristine—kidney cancer	0.000376	0.00116	CcSEcCtD
Disopyramide—Pruritus—Erlotinib—kidney cancer	0.000376	0.00116	CcSEcCtD
Disopyramide—Fatigue—Dactinomycin—kidney cancer	0.000375	0.00115	CcSEcCtD
Disopyramide—Flatulence—Paclitaxel—kidney cancer	0.000373	0.00115	CcSEcCtD
Disopyramide—Pain—Dactinomycin—kidney cancer	0.000372	0.00115	CcSEcCtD
Disopyramide—Tension—Paclitaxel—kidney cancer	0.000371	0.00114	CcSEcCtD
Disopyramide—Agranulocytosis—Capecitabine—kidney cancer	0.000371	0.00114	CcSEcCtD
Disopyramide—Anorexia—Vincristine—kidney cancer	0.000371	0.00114	CcSEcCtD
Disopyramide—Dysgeusia—Paclitaxel—kidney cancer	0.000371	0.00114	CcSEcCtD
Disopyramide—Oedema—Gemcitabine—kidney cancer	0.000369	0.00114	CcSEcCtD
Disopyramide—Nervousness—Paclitaxel—kidney cancer	0.000368	0.00113	CcSEcCtD
Disopyramide—Cardiac failure congestive—Doxorubicin—kidney cancer	0.000367	0.00113	CcSEcCtD
Disopyramide—Dizziness—Vinblastine—kidney cancer	0.000365	0.00112	CcSEcCtD
Disopyramide—Dizziness—Everolimus—kidney cancer	0.000364	0.00112	CcSEcCtD
Disopyramide—Body temperature increased—Sunitinib—kidney cancer	0.000364	0.00112	CcSEcCtD
Disopyramide—Diarrhoea—Erlotinib—kidney cancer	0.000363	0.00112	CcSEcCtD
Disopyramide—Hypotension—Vincristine—kidney cancer	0.000363	0.00112	CcSEcCtD
Disopyramide—Bradycardia—Capecitabine—kidney cancer	0.000363	0.00112	CcSEcCtD
Disopyramide—Thrombocytopenia—Gemcitabine—kidney cancer	0.000361	0.00111	CcSEcCtD
Disopyramide—Feeling abnormal—Dactinomycin—kidney cancer	0.000359	0.0011	CcSEcCtD
Disopyramide—Skin disorder—Gemcitabine—kidney cancer	0.000358	0.0011	CcSEcCtD
Disopyramide—Hepatitis—Capecitabine—kidney cancer	0.000357	0.0011	CcSEcCtD
Disopyramide—Vision blurred—Paclitaxel—kidney cancer	0.000357	0.0011	CcSEcCtD
Disopyramide—Hyperhidrosis—Gemcitabine—kidney cancer	0.000357	0.0011	CcSEcCtD
Disopyramide—Hypoaesthesia—Capecitabine—kidney cancer	0.000355	0.00109	CcSEcCtD
Disopyramide—Insomnia—Vincristine—kidney cancer	0.000352	0.00108	CcSEcCtD
Disopyramide—Anorexia—Gemcitabine—kidney cancer	0.000352	0.00108	CcSEcCtD
Disopyramide—Vomiting—Vinblastine—kidney cancer	0.000351	0.00108	CcSEcCtD
Disopyramide—Dizziness—Erlotinib—kidney cancer	0.000351	0.00108	CcSEcCtD
Disopyramide—Ill-defined disorder—Paclitaxel—kidney cancer	0.000351	0.00108	CcSEcCtD
Disopyramide—Vomiting—Everolimus—kidney cancer	0.00035	0.00108	CcSEcCtD
Disopyramide—Paraesthesia—Vincristine—kidney cancer	0.000349	0.00107	CcSEcCtD
Disopyramide—Rash—Everolimus—kidney cancer	0.000347	0.00107	CcSEcCtD
Disopyramide—Dermatitis—Everolimus—kidney cancer	0.000347	0.00107	CcSEcCtD
Disopyramide—Headache—Vinblastine—kidney cancer	0.000346	0.00107	CcSEcCtD
Disopyramide—Angioedema—Paclitaxel—kidney cancer	0.000346	0.00106	CcSEcCtD
Disopyramide—Headache—Everolimus—kidney cancer	0.000345	0.00106	CcSEcCtD
Disopyramide—Hypotension—Gemcitabine—kidney cancer	0.000345	0.00106	CcSEcCtD
Disopyramide—Body temperature increased—Dactinomycin—kidney cancer	0.000344	0.00106	CcSEcCtD
Disopyramide—Asthenia—Sorafenib—kidney cancer	0.000343	0.00105	CcSEcCtD
Disopyramide—Malaise—Paclitaxel—kidney cancer	0.000341	0.00105	CcSEcCtD
Disopyramide—Hypoglycaemia—Doxorubicin—kidney cancer	0.000341	0.00105	CcSEcCtD
Disopyramide—Cardiac failure—Doxorubicin—kidney cancer	0.000341	0.00105	CcSEcCtD
Disopyramide—Vertigo—Paclitaxel—kidney cancer	0.00034	0.00105	CcSEcCtD
Disopyramide—Syncope—Paclitaxel—kidney cancer	0.000339	0.00104	CcSEcCtD
Disopyramide—Decreased appetite—Vincristine—kidney cancer	0.000338	0.00104	CcSEcCtD
Disopyramide—Pruritus—Sorafenib—kidney cancer	0.000338	0.00104	CcSEcCtD
Disopyramide—Vomiting—Erlotinib—kidney cancer	0.000338	0.00104	CcSEcCtD
Disopyramide—Fatigue—Vincristine—kidney cancer	0.000335	0.00103	CcSEcCtD
Disopyramide—Rash—Erlotinib—kidney cancer	0.000335	0.00103	CcSEcCtD
Disopyramide—Dermatitis—Erlotinib—kidney cancer	0.000335	0.00103	CcSEcCtD
Disopyramide—Insomnia—Gemcitabine—kidney cancer	0.000334	0.00103	CcSEcCtD
Disopyramide—Headache—Erlotinib—kidney cancer	0.000333	0.00102	CcSEcCtD
Disopyramide—Loss of consciousness—Paclitaxel—kidney cancer	0.000333	0.00102	CcSEcCtD
Disopyramide—Constipation—Vincristine—kidney cancer	0.000333	0.00102	CcSEcCtD
Disopyramide—Pain—Vincristine—kidney cancer	0.000333	0.00102	CcSEcCtD
Disopyramide—Diplopia—Doxorubicin—kidney cancer	0.000332	0.00102	CcSEcCtD
Disopyramide—Paraesthesia—Gemcitabine—kidney cancer	0.000331	0.00102	CcSEcCtD
Disopyramide—Asthenia—Sunitinib—kidney cancer	0.00033	0.00101	CcSEcCtD
Disopyramide—Dyspnoea—Gemcitabine—kidney cancer	0.000329	0.00101	CcSEcCtD
Disopyramide—Nausea—Vinblastine—kidney cancer	0.000328	0.00101	CcSEcCtD
Disopyramide—Somnolence—Gemcitabine—kidney cancer	0.000328	0.00101	CcSEcCtD
Disopyramide—Nausea—Everolimus—kidney cancer	0.000327	0.00101	CcSEcCtD
Disopyramide—Diarrhoea—Sorafenib—kidney cancer	0.000327	0.00101	CcSEcCtD
Disopyramide—Pruritus—Sunitinib—kidney cancer	0.000325	0.001	CcSEcCtD
Disopyramide—Chest pain—Paclitaxel—kidney cancer	0.000322	0.000991	CcSEcCtD
Disopyramide—Decreased appetite—Gemcitabine—kidney cancer	0.000321	0.000987	CcSEcCtD
Disopyramide—Arrhythmia—Capecitabine—kidney cancer	0.000319	0.000981	CcSEcCtD
Disopyramide—Discomfort—Paclitaxel—kidney cancer	0.000318	0.000979	CcSEcCtD
Disopyramide—Fatigue—Gemcitabine—kidney cancer	0.000318	0.000979	CcSEcCtD
Disopyramide—Cardiac arrest—Doxorubicin—kidney cancer	0.000316	0.000973	CcSEcCtD
Disopyramide—Dizziness—Sorafenib—kidney cancer	0.000316	0.000972	CcSEcCtD
Disopyramide—Constipation—Gemcitabine—kidney cancer	0.000316	0.000971	CcSEcCtD
Disopyramide—Pain—Gemcitabine—kidney cancer	0.000316	0.000971	CcSEcCtD
Disopyramide—Nausea—Erlotinib—kidney cancer	0.000316	0.000971	CcSEcCtD
Disopyramide—Dry mouth—Paclitaxel—kidney cancer	0.000315	0.000969	CcSEcCtD
Disopyramide—Diarrhoea—Sunitinib—kidney cancer	0.000315	0.000968	CcSEcCtD
Disopyramide—Asthenia—Dactinomycin—kidney cancer	0.000312	0.000961	CcSEcCtD
Disopyramide—Confusional state—Paclitaxel—kidney cancer	0.000311	0.000958	CcSEcCtD
Disopyramide—Blood creatinine increased—Doxorubicin—kidney cancer	0.000311	0.000958	CcSEcCtD
Disopyramide—Oedema—Paclitaxel—kidney cancer	0.000309	0.00095	CcSEcCtD
Disopyramide—Body temperature increased—Vincristine—kidney cancer	0.000307	0.000946	CcSEcCtD
Disopyramide—Flatulence—Capecitabine—kidney cancer	0.000306	0.000942	CcSEcCtD
Disopyramide—Dysgeusia—Capecitabine—kidney cancer	0.000304	0.000936	CcSEcCtD
Disopyramide—Dizziness—Sunitinib—kidney cancer	0.000304	0.000935	CcSEcCtD
Disopyramide—Feeling abnormal—Gemcitabine—kidney cancer	0.000304	0.000935	CcSEcCtD
Disopyramide—Shock—Paclitaxel—kidney cancer	0.000304	0.000935	CcSEcCtD
Disopyramide—Vomiting—Sorafenib—kidney cancer	0.000304	0.000935	CcSEcCtD
Disopyramide—Abdominal pain upper—Doxorubicin—kidney cancer	0.000304	0.000934	CcSEcCtD
Disopyramide—Hypokalaemia—Doxorubicin—kidney cancer	0.000303	0.000931	CcSEcCtD
Disopyramide—Thrombocytopenia—Paclitaxel—kidney cancer	0.000302	0.00093	CcSEcCtD
Disopyramide—Rash—Sorafenib—kidney cancer	0.000301	0.000927	CcSEcCtD
Disopyramide—Dermatitis—Sorafenib—kidney cancer	0.000301	0.000926	CcSEcCtD
Disopyramide—Skin disorder—Paclitaxel—kidney cancer	0.0003	0.000923	CcSEcCtD
Disopyramide—Headache—Sorafenib—kidney cancer	0.000299	0.000921	CcSEcCtD
Disopyramide—Hyperhidrosis—Paclitaxel—kidney cancer	0.000299	0.000919	CcSEcCtD
Disopyramide—Diarrhoea—Dactinomycin—kidney cancer	0.000298	0.000916	CcSEcCtD
Disopyramide—Anorexia—Paclitaxel—kidney cancer	0.000294	0.000906	CcSEcCtD
Disopyramide—Muscular weakness—Doxorubicin—kidney cancer	0.000293	0.000902	CcSEcCtD
Disopyramide—Vision blurred—Capecitabine—kidney cancer	0.000293	0.000901	CcSEcCtD
Disopyramide—Vomiting—Sunitinib—kidney cancer	0.000292	0.000899	CcSEcCtD
Disopyramide—Body temperature increased—Gemcitabine—kidney cancer	0.000292	0.000897	CcSEcCtD
Disopyramide—Rash—Sunitinib—kidney cancer	0.00029	0.000892	CcSEcCtD
Disopyramide—Dermatitis—Sunitinib—kidney cancer	0.00029	0.000891	CcSEcCtD
Disopyramide—Abdominal distension—Doxorubicin—kidney cancer	0.000289	0.00089	CcSEcCtD
Disopyramide—Hypotension—Paclitaxel—kidney cancer	0.000289	0.000888	CcSEcCtD
Disopyramide—Ill-defined disorder—Capecitabine—kidney cancer	0.000288	0.000887	CcSEcCtD
Disopyramide—Headache—Sunitinib—kidney cancer	0.000288	0.000886	CcSEcCtD
Disopyramide—Nausea—Sorafenib—kidney cancer	0.000284	0.000873	CcSEcCtD
Disopyramide—Malaise—Capecitabine—kidney cancer	0.00028	0.000862	CcSEcCtD
Disopyramide—Insomnia—Paclitaxel—kidney cancer	0.000279	0.00086	CcSEcCtD
Disopyramide—Vertigo—Capecitabine—kidney cancer	0.000279	0.000859	CcSEcCtD
Disopyramide—Asthenia—Vincristine—kidney cancer	0.000279	0.000858	CcSEcCtD
Disopyramide—Syncope—Capecitabine—kidney cancer	0.000279	0.000857	CcSEcCtD
Disopyramide—Paraesthesia—Paclitaxel—kidney cancer	0.000277	0.000853	CcSEcCtD
Disopyramide—Vomiting—Dactinomycin—kidney cancer	0.000277	0.000851	CcSEcCtD
Disopyramide—Dyspnoea—Paclitaxel—kidney cancer	0.000275	0.000847	CcSEcCtD
Disopyramide—Somnolence—Paclitaxel—kidney cancer	0.000275	0.000845	CcSEcCtD
Disopyramide—Rash—Dactinomycin—kidney cancer	0.000274	0.000844	CcSEcCtD
Disopyramide—Nausea—Sunitinib—kidney cancer	0.000273	0.00084	CcSEcCtD
Disopyramide—Loss of consciousness—Capecitabine—kidney cancer	0.000273	0.00084	CcSEcCtD
Disopyramide—Dyspepsia—Paclitaxel—kidney cancer	0.000272	0.000837	CcSEcCtD
Disopyramide—Dysuria—Doxorubicin—kidney cancer	0.000269	0.000827	CcSEcCtD
Disopyramide—Neutropenia—Doxorubicin—kidney cancer	0.000269	0.000827	CcSEcCtD
Disopyramide—Decreased appetite—Paclitaxel—kidney cancer	0.000269	0.000826	CcSEcCtD
Disopyramide—Fatigue—Paclitaxel—kidney cancer	0.000266	0.000819	CcSEcCtD
Disopyramide—Diarrhoea—Vincristine—kidney cancer	0.000266	0.000819	CcSEcCtD
Disopyramide—Pollakiuria—Doxorubicin—kidney cancer	0.000265	0.000817	CcSEcCtD
Disopyramide—Asthenia—Gemcitabine—kidney cancer	0.000265	0.000814	CcSEcCtD
Disopyramide—Chest pain—Capecitabine—kidney cancer	0.000264	0.000814	CcSEcCtD
Disopyramide—Constipation—Paclitaxel—kidney cancer	0.000264	0.000813	CcSEcCtD
Disopyramide—Pain—Paclitaxel—kidney cancer	0.000264	0.000813	CcSEcCtD
Disopyramide—Weight increased—Doxorubicin—kidney cancer	0.000262	0.000804	CcSEcCtD
Disopyramide—Discomfort—Capecitabine—kidney cancer	0.000261	0.000804	CcSEcCtD
Disopyramide—Pruritus—Gemcitabine—kidney cancer	0.000261	0.000803	CcSEcCtD
Disopyramide—Dry mouth—Capecitabine—kidney cancer	0.000259	0.000796	CcSEcCtD
Disopyramide—Nausea—Dactinomycin—kidney cancer	0.000259	0.000795	CcSEcCtD
Disopyramide—Dizziness—Vincristine—kidney cancer	0.000257	0.000791	CcSEcCtD
Disopyramide—Drowsiness—Doxorubicin—kidney cancer	0.000256	0.000788	CcSEcCtD
Disopyramide—Confusional state—Capecitabine—kidney cancer	0.000256	0.000786	CcSEcCtD
Disopyramide—Feeling abnormal—Paclitaxel—kidney cancer	0.000255	0.000783	CcSEcCtD
Disopyramide—Oedema—Capecitabine—kidney cancer	0.000254	0.00078	CcSEcCtD
Disopyramide—Diarrhoea—Gemcitabine—kidney cancer	0.000252	0.000777	CcSEcCtD
Disopyramide—Shock—Capecitabine—kidney cancer	0.000249	0.000767	CcSEcCtD
Disopyramide—Thrombocytopenia—Capecitabine—kidney cancer	0.000248	0.000764	CcSEcCtD
Disopyramide—Vomiting—Vincristine—kidney cancer	0.000247	0.000761	CcSEcCtD
Disopyramide—Skin disorder—Capecitabine—kidney cancer	0.000246	0.000757	CcSEcCtD
Disopyramide—Urticaria—Paclitaxel—kidney cancer	0.000245	0.000755	CcSEcCtD
Disopyramide—Rash—Vincristine—kidney cancer	0.000245	0.000754	CcSEcCtD
Disopyramide—Hyperhidrosis—Capecitabine—kidney cancer	0.000245	0.000754	CcSEcCtD
Disopyramide—Dermatitis—Vincristine—kidney cancer	0.000245	0.000754	CcSEcCtD
Disopyramide—Body temperature increased—Paclitaxel—kidney cancer	0.000244	0.000751	CcSEcCtD
Disopyramide—Headache—Vincristine—kidney cancer	0.000244	0.00075	CcSEcCtD
Disopyramide—Anorexia—Capecitabine—kidney cancer	0.000242	0.000743	CcSEcCtD
Disopyramide—Agranulocytosis—Doxorubicin—kidney cancer	0.000239	0.000736	CcSEcCtD
Disopyramide—Hypotension—Capecitabine—kidney cancer	0.000237	0.000729	CcSEcCtD
Disopyramide—Vomiting—Gemcitabine—kidney cancer	0.000235	0.000722	CcSEcCtD
Disopyramide—Bradycardia—Doxorubicin—kidney cancer	0.000234	0.00072	CcSEcCtD
Disopyramide—Rash—Gemcitabine—kidney cancer	0.000233	0.000716	CcSEcCtD
Disopyramide—Dermatitis—Gemcitabine—kidney cancer	0.000232	0.000715	CcSEcCtD
Disopyramide—Headache—Gemcitabine—kidney cancer	0.000231	0.000711	CcSEcCtD
Disopyramide—Nausea—Vincristine—kidney cancer	0.000231	0.000711	CcSEcCtD
Disopyramide—Hepatitis—Doxorubicin—kidney cancer	0.00023	0.000708	CcSEcCtD
Disopyramide—Insomnia—Capecitabine—kidney cancer	0.000229	0.000705	CcSEcCtD
Disopyramide—Hypoaesthesia—Doxorubicin—kidney cancer	0.000229	0.000704	CcSEcCtD
Disopyramide—Paraesthesia—Capecitabine—kidney cancer	0.000228	0.0007	CcSEcCtD
Disopyramide—Dyspnoea—Capecitabine—kidney cancer	0.000226	0.000695	CcSEcCtD
Disopyramide—Dyspepsia—Capecitabine—kidney cancer	0.000223	0.000686	CcSEcCtD
Disopyramide—Asthenia—Paclitaxel—kidney cancer	0.000222	0.000682	CcSEcCtD
Disopyramide—Decreased appetite—Capecitabine—kidney cancer	0.00022	0.000678	CcSEcCtD
Disopyramide—Nausea—Gemcitabine—kidney cancer	0.000219	0.000674	CcSEcCtD
Disopyramide—Fatigue—Capecitabine—kidney cancer	0.000219	0.000672	CcSEcCtD
Disopyramide—Pruritus—Paclitaxel—kidney cancer	0.000219	0.000672	CcSEcCtD
Disopyramide—Constipation—Capecitabine—kidney cancer	0.000217	0.000667	CcSEcCtD
Disopyramide—Pain—Capecitabine—kidney cancer	0.000217	0.000667	CcSEcCtD
Disopyramide—Diarrhoea—Paclitaxel—kidney cancer	0.000211	0.00065	CcSEcCtD
Disopyramide—Feeling abnormal—Capecitabine—kidney cancer	0.000209	0.000643	CcSEcCtD
Disopyramide—Arrhythmia—Doxorubicin—kidney cancer	0.000205	0.000632	CcSEcCtD
Disopyramide—Dizziness—Paclitaxel—kidney cancer	0.000204	0.000628	CcSEcCtD
Disopyramide—Urticaria—Capecitabine—kidney cancer	0.000201	0.00062	CcSEcCtD
Disopyramide—Body temperature increased—Capecitabine—kidney cancer	0.0002	0.000616	CcSEcCtD
Disopyramide—Flatulence—Doxorubicin—kidney cancer	0.000197	0.000607	CcSEcCtD
Disopyramide—Tension—Doxorubicin—kidney cancer	0.000196	0.000604	CcSEcCtD
Disopyramide—Vomiting—Paclitaxel—kidney cancer	0.000196	0.000604	CcSEcCtD
Disopyramide—Dysgeusia—Doxorubicin—kidney cancer	0.000196	0.000603	CcSEcCtD
Disopyramide—Rash—Paclitaxel—kidney cancer	0.000195	0.000599	CcSEcCtD
Disopyramide—Dermatitis—Paclitaxel—kidney cancer	0.000195	0.000599	CcSEcCtD
Disopyramide—Nervousness—Doxorubicin—kidney cancer	0.000194	0.000598	CcSEcCtD
Disopyramide—Headache—Paclitaxel—kidney cancer	0.000194	0.000595	CcSEcCtD
Disopyramide—Vision blurred—Doxorubicin—kidney cancer	0.000189	0.00058	CcSEcCtD
Disopyramide—Ill-defined disorder—Doxorubicin—kidney cancer	0.000186	0.000571	CcSEcCtD
Disopyramide—Nausea—Paclitaxel—kidney cancer	0.000183	0.000564	CcSEcCtD
Disopyramide—Asthenia—Capecitabine—kidney cancer	0.000182	0.00056	CcSEcCtD
Disopyramide—Malaise—Doxorubicin—kidney cancer	0.000181	0.000555	CcSEcCtD
Disopyramide—Vertigo—Doxorubicin—kidney cancer	0.00018	0.000553	CcSEcCtD
Disopyramide—Syncope—Doxorubicin—kidney cancer	0.00018	0.000552	CcSEcCtD
Disopyramide—Pruritus—Capecitabine—kidney cancer	0.000179	0.000552	CcSEcCtD
Disopyramide—Loss of consciousness—Doxorubicin—kidney cancer	0.000176	0.000541	CcSEcCtD
Disopyramide—Diarrhoea—Capecitabine—kidney cancer	0.000173	0.000534	CcSEcCtD
Disopyramide—Chest pain—Doxorubicin—kidney cancer	0.00017	0.000524	CcSEcCtD
Disopyramide—Discomfort—Doxorubicin—kidney cancer	0.000168	0.000518	CcSEcCtD
Disopyramide—Dizziness—Capecitabine—kidney cancer	0.000168	0.000516	CcSEcCtD
Disopyramide—Dry mouth—Doxorubicin—kidney cancer	0.000167	0.000513	CcSEcCtD
Disopyramide—Confusional state—Doxorubicin—kidney cancer	0.000165	0.000507	CcSEcCtD
Disopyramide—Oedema—Doxorubicin—kidney cancer	0.000163	0.000503	CcSEcCtD
Disopyramide—Vomiting—Capecitabine—kidney cancer	0.000161	0.000496	CcSEcCtD
Disopyramide—Shock—Doxorubicin—kidney cancer	0.000161	0.000495	CcSEcCtD
Disopyramide—Thrombocytopenia—Doxorubicin—kidney cancer	0.00016	0.000492	CcSEcCtD
Disopyramide—Rash—Capecitabine—kidney cancer	0.00016	0.000492	CcSEcCtD
Disopyramide—Dermatitis—Capecitabine—kidney cancer	0.00016	0.000491	CcSEcCtD
Disopyramide—Headache—Capecitabine—kidney cancer	0.000159	0.000489	CcSEcCtD
Disopyramide—Skin disorder—Doxorubicin—kidney cancer	0.000159	0.000488	CcSEcCtD
Disopyramide—Hyperhidrosis—Doxorubicin—kidney cancer	0.000158	0.000486	CcSEcCtD
Disopyramide—Anorexia—Doxorubicin—kidney cancer	0.000156	0.000479	CcSEcCtD
Disopyramide—Hypotension—Doxorubicin—kidney cancer	0.000153	0.00047	CcSEcCtD
Disopyramide—Nausea—Capecitabine—kidney cancer	0.000151	0.000463	CcSEcCtD
Disopyramide—Insomnia—Doxorubicin—kidney cancer	0.000148	0.000455	CcSEcCtD
Disopyramide—Paraesthesia—Doxorubicin—kidney cancer	0.000147	0.000451	CcSEcCtD
Disopyramide—Dyspnoea—Doxorubicin—kidney cancer	0.000146	0.000448	CcSEcCtD
Disopyramide—Somnolence—Doxorubicin—kidney cancer	0.000145	0.000447	CcSEcCtD
Disopyramide—Dyspepsia—Doxorubicin—kidney cancer	0.000144	0.000443	CcSEcCtD
Disopyramide—Decreased appetite—Doxorubicin—kidney cancer	0.000142	0.000437	CcSEcCtD
Disopyramide—Fatigue—Doxorubicin—kidney cancer	0.000141	0.000433	CcSEcCtD
Disopyramide—Pain—Doxorubicin—kidney cancer	0.00014	0.00043	CcSEcCtD
Disopyramide—Constipation—Doxorubicin—kidney cancer	0.00014	0.00043	CcSEcCtD
Disopyramide—Feeling abnormal—Doxorubicin—kidney cancer	0.000135	0.000414	CcSEcCtD
Disopyramide—Urticaria—Doxorubicin—kidney cancer	0.00013	0.000399	CcSEcCtD
Disopyramide—Body temperature increased—Doxorubicin—kidney cancer	0.000129	0.000397	CcSEcCtD
Disopyramide—Asthenia—Doxorubicin—kidney cancer	0.000117	0.000361	CcSEcCtD
Disopyramide—Pruritus—Doxorubicin—kidney cancer	0.000116	0.000356	CcSEcCtD
Disopyramide—Diarrhoea—Doxorubicin—kidney cancer	0.000112	0.000344	CcSEcCtD
Disopyramide—Dizziness—Doxorubicin—kidney cancer	0.000108	0.000332	CcSEcCtD
Disopyramide—Vomiting—Doxorubicin—kidney cancer	0.000104	0.00032	CcSEcCtD
Disopyramide—Rash—Doxorubicin—kidney cancer	0.000103	0.000317	CcSEcCtD
Disopyramide—Dermatitis—Doxorubicin—kidney cancer	0.000103	0.000317	CcSEcCtD
Disopyramide—Headache—Doxorubicin—kidney cancer	0.000102	0.000315	CcSEcCtD
Disopyramide—Nausea—Doxorubicin—kidney cancer	9.71e-05	0.000299	CcSEcCtD
Disopyramide—CHRM2—GPCR ligand binding—POMC—kidney cancer	2.9e-05	0.000452	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—MAPK1—kidney cancer	2.9e-05	0.000452	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ACY1—kidney cancer	2.86e-05	0.000447	CbGpPWpGaD
Disopyramide—CHRM1—G alpha (q) signalling events—PIK3CA—kidney cancer	2.86e-05	0.000446	CbGpPWpGaD
Disopyramide—CHRM3—G alpha (q) signalling events—PIK3CA—kidney cancer	2.85e-05	0.000444	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—ITPR2—kidney cancer	2.8e-05	0.000437	CbGpPWpGaD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	2.78e-05	0.000434	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CRABP1—kidney cancer	2.78e-05	0.000434	CbGpPWpGaD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	2.77e-05	0.000433	CbGpPWpGaD
Disopyramide—SLC22A2—Neuronal System—MAPK1—kidney cancer	2.77e-05	0.000432	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—GSTT1—kidney cancer	2.74e-05	0.000427	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—ACHE—kidney cancer	2.74e-05	0.000427	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—KRAS—kidney cancer	2.74e-05	0.000427	CbGpPWpGaD
Disopyramide—CHRM1—Circadian rythm related genes—TP53—kidney cancer	2.61e-05	0.000407	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—SCARB1—kidney cancer	2.59e-05	0.000404	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—ITPR2—kidney cancer	2.59e-05	0.000403	CbGpPWpGaD
Disopyramide—SLC22A1—Neuronal System—MAPK1—kidney cancer	2.58e-05	0.000403	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PTGS1—kidney cancer	2.57e-05	0.0004	CbGpPWpGaD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	2.56e-05	0.000399	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—GSTT1—kidney cancer	2.55e-05	0.000398	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—ACHE—kidney cancer	2.55e-05	0.000398	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—AKAP13—kidney cancer	2.55e-05	0.000398	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CASP2—kidney cancer	2.55e-05	0.000398	CbGpPWpGaD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	2.55e-05	0.000397	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—AKAP13—kidney cancer	2.54e-05	0.000397	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CASP2—kidney cancer	2.54e-05	0.000397	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CASP2—kidney cancer	2.52e-05	0.000393	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—AKAP13—kidney cancer	2.52e-05	0.000393	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PSMD7—kidney cancer	2.52e-05	0.000393	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PDHB—kidney cancer	2.43e-05	0.00038	CbGpPWpGaD
Disopyramide—CYP3A4—Biological oxidations—POMC—kidney cancer	2.43e-05	0.000378	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—SCARB1—kidney cancer	2.42e-05	0.000377	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PTGS1—kidney cancer	2.39e-05	0.000373	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—BCHE—kidney cancer	2.39e-05	0.000372	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—ACHE—kidney cancer	2.36e-05	0.000368	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—GSTT1—kidney cancer	2.36e-05	0.000368	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—SLC5A5—kidney cancer	2.36e-05	0.000368	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PSMD7—kidney cancer	2.35e-05	0.000366	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—GRB7—kidney cancer	2.33e-05	0.000364	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—GRB7—kidney cancer	2.33e-05	0.000363	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—GRB7—kidney cancer	2.3e-05	0.000359	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CCBL1—kidney cancer	2.29e-05	0.000357	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—SLC2A1—kidney cancer	2.28e-05	0.000355	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—SCARB1—kidney cancer	2.23e-05	0.000348	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—BCHE—kidney cancer	2.22e-05	0.000347	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PTGS1—kidney cancer	2.21e-05	0.000345	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—SLC5A5—kidney cancer	2.2e-05	0.000343	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—RAF1—kidney cancer	2.17e-05	0.000339	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—ITPR2—kidney cancer	2.17e-05	0.000338	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PSMD7—kidney cancer	2.17e-05	0.000338	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—ITPR2—kidney cancer	2.16e-05	0.000337	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—ITPR2—kidney cancer	2.14e-05	0.000334	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—SLC2A1—kidney cancer	2.12e-05	0.000331	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—BCHE—kidney cancer	2.05e-05	0.00032	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—SLC5A5—kidney cancer	2.03e-05	0.000316	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—RAF1—kidney cancer	2.02e-05	0.000316	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.98e-05	0.00031	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PPAT—kidney cancer	1.98e-05	0.00031	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CTNNA1—kidney cancer	1.97e-05	0.000307	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CTNNA1—kidney cancer	1.96e-05	0.000306	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—SLC2A1—kidney cancer	1.96e-05	0.000306	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—HSPB1—kidney cancer	1.96e-05	0.000305	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—EIF4EBP1—kidney cancer	1.96e-05	0.000305	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—EIF4EBP1—kidney cancer	1.95e-05	0.000304	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—HSPB1—kidney cancer	1.95e-05	0.000304	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CTNNA1—kidney cancer	1.94e-05	0.000303	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—EIF4EBP1—kidney cancer	1.93e-05	0.000301	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—HSPB1—kidney cancer	1.93e-05	0.000301	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—GSTP1—kidney cancer	1.9e-05	0.000296	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—FH—kidney cancer	1.85e-05	0.000288	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—APRT—kidney cancer	1.85e-05	0.000288	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TSC1—kidney cancer	1.82e-05	0.000283	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PSMD7—kidney cancer	1.82e-05	0.000283	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—ANXA1—kidney cancer	1.82e-05	0.000283	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PSMD7—kidney cancer	1.81e-05	0.000283	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TSC1—kidney cancer	1.81e-05	0.000283	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—ANXA1—kidney cancer	1.81e-05	0.000283	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—ABCB1—kidney cancer	1.8e-05	0.00028	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—ANXA1—kidney cancer	1.79e-05	0.00028	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PSMD7—kidney cancer	1.79e-05	0.00028	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TSC1—kidney cancer	1.79e-05	0.00028	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—GSTP1—kidney cancer	1.77e-05	0.000276	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—FLT1—kidney cancer	1.76e-05	0.000275	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—FLT1—kidney cancer	1.75e-05	0.000274	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—GSTM1—kidney cancer	1.74e-05	0.000272	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—FLT1—kidney cancer	1.74e-05	0.000271	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GPC3—kidney cancer	1.73e-05	0.000271	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CA2—kidney cancer	1.69e-05	0.000263	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—ABCB1—kidney cancer	1.68e-05	0.000261	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—POMC—kidney cancer	1.66e-05	0.000259	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—POMC—kidney cancer	1.65e-05	0.000258	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—CYP1A1—kidney cancer	1.65e-05	0.000258	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ALAD—kidney cancer	1.64e-05	0.000256	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—POMC—kidney cancer	1.64e-05	0.000256	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—GSTP1—kidney cancer	1.63e-05	0.000255	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—JUNB—kidney cancer	1.63e-05	0.000255	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PAK1—kidney cancer	1.63e-05	0.000255	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PAK1—kidney cancer	1.63e-05	0.000254	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—JUNB—kidney cancer	1.63e-05	0.000254	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—GSTM1—kidney cancer	1.63e-05	0.000254	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PAK1—kidney cancer	1.61e-05	0.000251	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—JUNB—kidney cancer	1.61e-05	0.000251	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.61e-05	0.00025	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.57e-05	0.000245	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—ABCB1—kidney cancer	1.55e-05	0.000241	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—CYP1A1—kidney cancer	1.54e-05	0.00024	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—POMC—kidney cancer	1.51e-05	0.000235	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PGK1—kidney cancer	1.5e-05	0.000235	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.5e-05	0.000235	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—POMC—kidney cancer	1.5e-05	0.000234	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—GSTM1—kidney cancer	1.5e-05	0.000234	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—POMC—kidney cancer	1.49e-05	0.000232	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—LDHB—kidney cancer	1.48e-05	0.00023	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CYP1A1—kidney cancer	1.42e-05	0.000222	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IGF2—kidney cancer	1.33e-05	0.000208	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IGF2—kidney cancer	1.33e-05	0.000207	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CDKN2B—kidney cancer	1.33e-05	0.000207	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CDKN2B—kidney cancer	1.32e-05	0.000207	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IGF2—kidney cancer	1.32e-05	0.000205	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CDKN2B—kidney cancer	1.31e-05	0.000205	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IGF1R—kidney cancer	1.29e-05	0.000201	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IGF1R—kidney cancer	1.29e-05	0.000201	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CA9—kidney cancer	1.28e-05	0.000199	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IGF1R—kidney cancer	1.27e-05	0.000199	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—RAF1—kidney cancer	1.24e-05	0.000194	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—RAF1—kidney cancer	1.24e-05	0.000193	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—POMC—kidney cancer	1.23e-05	0.000192	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—IL2—kidney cancer	1.23e-05	0.000191	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—RAF1—kidney cancer	1.23e-05	0.000191	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—IL2—kidney cancer	1.22e-05	0.000191	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—IL2—kidney cancer	1.21e-05	0.000189	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—POMC—kidney cancer	1.15e-05	0.000179	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—IL2—kidney cancer	1.11e-05	0.000174	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—IL2—kidney cancer	1.11e-05	0.000173	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—IL2—kidney cancer	1.1e-05	0.000172	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CRABP1—kidney cancer	1.09e-05	0.00017	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—HIF1A—kidney cancer	1.06e-05	0.000166	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—POMC—kidney cancer	1.06e-05	0.000166	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TSC2—kidney cancer	1.06e-05	0.000165	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—HIF1A—kidney cancer	1.06e-05	0.000165	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TSC2—kidney cancer	1.06e-05	0.000165	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—HIF1A—kidney cancer	1.05e-05	0.000163	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TSC2—kidney cancer	1.05e-05	0.000163	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—KDR—kidney cancer	1.02e-05	0.000158	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—KDR—kidney cancer	1.01e-05	0.000158	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ITPR2—kidney cancer	1.01e-05	0.000158	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—KDR—kidney cancer	1e-05	0.000156	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PTGS2—kidney cancer	9.84e-06	0.000153	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—APC—kidney cancer	9.36e-06	0.000146	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—KIT—kidney cancer	9.36e-06	0.000146	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—KIT—kidney cancer	9.33e-06	0.000145	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—APC—kidney cancer	9.33e-06	0.000145	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—KIT—kidney cancer	9.24e-06	0.000144	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—APC—kidney cancer	9.24e-06	0.000144	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GSTT1—kidney cancer	9.22e-06	0.000144	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ACHE—kidney cancer	9.22e-06	0.000144	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PTGS2—kidney cancer	9.17e-06	0.000143	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—MAPK3—kidney cancer	8.96e-06	0.00014	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—MAPK3—kidney cancer	8.93e-06	0.000139	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—POMC—kidney cancer	8.91e-06	0.000139	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—POMC—kidney cancer	8.88e-06	0.000138	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—MAPK3—kidney cancer	8.85e-06	0.000138	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—BRAF—kidney cancer	8.79e-06	0.000137	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—POMC—kidney cancer	8.79e-06	0.000137	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—BRAF—kidney cancer	8.77e-06	0.000137	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SCARB1—kidney cancer	8.73e-06	0.000136	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—BRAF—kidney cancer	8.68e-06	0.000135	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PTGS1—kidney cancer	8.64e-06	0.000135	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PTEN—kidney cancer	8.58e-06	0.000134	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—MAPK1—kidney cancer	8.53e-06	0.000133	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—MAPK1—kidney cancer	8.5e-06	0.000133	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PSMD7—kidney cancer	8.47e-06	0.000132	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PTGS2—kidney cancer	8.47e-06	0.000132	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—MAPK1—kidney cancer	8.42e-06	0.000131	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—PIK3CA—kidney cancer	8.15e-06	0.000127	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—PIK3CA—kidney cancer	8.12e-06	0.000127	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—KRAS—kidney cancer	8.05e-06	0.000126	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—PIK3CA—kidney cancer	8.04e-06	0.000125	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—BCHE—kidney cancer	8.03e-06	0.000125	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—KRAS—kidney cancer	8.03e-06	0.000125	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PTEN—kidney cancer	7.99e-06	0.000125	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—KRAS—kidney cancer	7.95e-06	0.000124	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SLC5A5—kidney cancer	7.93e-06	0.000124	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SLC2A1—kidney cancer	7.66e-06	0.000119	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—PIK3CA—kidney cancer	7.4e-06	0.000115	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PTEN—kidney cancer	7.39e-06	0.000115	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—PIK3CA—kidney cancer	7.37e-06	0.000115	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—RAF1—kidney cancer	7.34e-06	0.000115	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—RAF1—kidney cancer	7.32e-06	0.000114	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—RELA—kidney cancer	7.31e-06	0.000114	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—PIK3CA—kidney cancer	7.3e-06	0.000114	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—RELA—kidney cancer	7.29e-06	0.000114	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—ERBB2—kidney cancer	7.26e-06	0.000113	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—RAF1—kidney cancer	7.25e-06	0.000113	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—ERBB2—kidney cancer	7.24e-06	0.000113	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—RELA—kidney cancer	7.22e-06	0.000113	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—ERBB2—kidney cancer	7.17e-06	0.000112	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MTOR—kidney cancer	7.17e-06	0.000112	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MTOR—kidney cancer	7.15e-06	0.000111	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MTOR—kidney cancer	7.08e-06	0.00011	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CDKN1B—kidney cancer	6.73e-06	0.000105	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CDKN1B—kidney cancer	6.71e-06	0.000105	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CDKN1B—kidney cancer	6.64e-06	0.000104	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IL2—kidney cancer	6.58e-06	0.000103	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IL2—kidney cancer	6.56e-06	0.000102	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IL2—kidney cancer	6.5e-06	0.000101	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CCND1—kidney cancer	6.42e-06	0.0001	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—JUN—kidney cancer	6.4e-06	9.99e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CCND1—kidney cancer	6.4e-06	9.98e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GSTP1—kidney cancer	6.39e-06	9.97e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—JUN—kidney cancer	6.38e-06	9.96e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CTNNB1—kidney cancer	6.36e-06	9.91e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CCND1—kidney cancer	6.34e-06	9.88e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CTNNB1—kidney cancer	6.34e-06	9.88e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—JUN—kidney cancer	6.32e-06	9.86e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CTNNB1—kidney cancer	6.27e-06	9.78e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PTEN—kidney cancer	6.2e-06	9.66e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PTEN—kidney cancer	6.18e-06	9.63e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PTEN—kidney cancer	6.12e-06	9.54e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PIK3CA—kidney cancer	6.05e-06	9.44e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ABCB1—kidney cancer	6.05e-06	9.43e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GSTM1—kidney cancer	5.87e-06	9.16e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PIK3CA—kidney cancer	5.64e-06	8.8e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—VEGFA—kidney cancer	5.6e-06	8.73e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—VEGFA—kidney cancer	5.58e-06	8.7e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CYP1A1—kidney cancer	5.57e-06	8.68e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—VEGFA—kidney cancer	5.52e-06	8.61e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MAPK3—kidney cancer	5.29e-06	8.25e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MAPK3—kidney cancer	5.28e-06	8.23e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MAPK3—kidney cancer	5.23e-06	8.15e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PIK3CA—kidney cancer	5.21e-06	8.12e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MYC—kidney cancer	5.15e-06	8.03e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MYC—kidney cancer	5.13e-06	8e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MYC—kidney cancer	5.08e-06	7.93e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MAPK1—kidney cancer	5.04e-06	7.85e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MAPK1—kidney cancer	5.02e-06	7.83e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MAPK1—kidney cancer	4.97e-06	7.75e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—KRAS—kidney cancer	4.76e-06	7.42e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—KRAS—kidney cancer	4.74e-06	7.39e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—KRAS—kidney cancer	4.7e-06	7.32e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PIK3CA—kidney cancer	4.37e-06	6.82e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PIK3CA—kidney cancer	4.36e-06	6.79e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PIK3CA—kidney cancer	4.31e-06	6.73e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TP53—kidney cancer	4.23e-06	6.59e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TP53—kidney cancer	4.21e-06	6.57e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TP53—kidney cancer	4.17e-06	6.51e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—POMC—kidney cancer	4.15e-06	6.47e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PTGS2—kidney cancer	3.31e-06	5.16e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PTEN—kidney cancer	2.89e-06	4.5e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PIK3CA—kidney cancer	2.04e-06	3.18e-05	CbGpPWpGaD
